Research - OCTOBER 15, 2020

To read this full article you need to be subscribed to Newsline.

Sign in Sign up for a FREE subscription

Pandemic stokes already robust demand for real estate in life sciences sector

by Andrea Zander

The pandemic has accelerated momentum in the U.S. life sciences industry, particularly amid the race to produce a COVID-19 vaccine and develop other medicines for human ailments. The sector, which has reached new highs this year in R&D employment and venture-capital funding, is seeing a surge in demand for life sciences real estate in markets from longstanding centers like Boston to emerging hubs such as Pittsburgh, according to a new report from CBRE.

Forgot your username or password?

We use cookies and other tracking technologies to personalize your user experience on our site and perform site analytics. By clicking on “I accept”, you consent to our Privacy Policy.